LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 17

Search options

  1. Book ; Online ; E-Book: Fish and fish oil in health and disease prevention

    Raatz, Susan K. / Bibus, Douglas M.

    2016  

    Author's details edited by Susan K. Raatz, Douglas M. Bibus
    Language English
    Size 1 Online-Ressource (xiv, 367 Seiten), Illustrationen
    Publisher Elsevier
    Publishing place Amsterdam
    Publishing country Netherlands
    Document type Book ; Online ; E-Book
    Note Description based upon print version of record
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019162510
    ISBN 978-0-12-802845-2 ; 9780128028445 ; 0-12-802845-9 ; 0128028440
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  2. Article: United States menhaden oil could save billions in U.S. health care costs and improve IQ in children.

    Bibus, Douglas M

    Lipid technology

    2016  Volume 28, Issue 2, Page(s) 33–35

    Abstract: The United States menhaden oil annual production is sufficient to supply all of the recommended long chain Omega-3s for Americans over 55 with coronary heart disease (CHD) and pregnant and lactating women. According to a recent study, the utilization of ... ...

    Abstract The United States menhaden oil annual production is sufficient to supply all of the recommended long chain Omega-3s for Americans over 55 with coronary heart disease (CHD) and pregnant and lactating women. According to a recent study, the utilization of preventable intake levels could potentially save up to $1.7 billion annually in hospital costs alone. In addition, the remaining oil could be used to support a culture of enough Atlantic salmon to provide every pregnant and lactating woman in the U.S. with 8-12 ounces of fish per week, as recommended by the Food and Drug Administration (FDA), throughout the duration of pregnancy and lactation. Based on the FDA's quantitative assessment, this may result in a net increase of IQ by 5.5 points in children and improve their early age verbal development.
    Language English
    Publishing date 2016-02-18
    Publishing country England
    Document type Journal Article
    ZDB-ID 1053078-2
    ISSN 0956-666X
    ISSN 0956-666X
    DOI 10.1002/lite.201600008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Long-chain omega-3 from low-trophic-level fish provides value to farmed seafood.

    Bibus, Douglas M

    Lipid technology

    2015  Volume 27, Issue 3, Page(s) 55–58

    Abstract: Low-trophic-level fish are a crucial source of long-chain (LC) omega-3 fatty acids for farmed fish and humans. Many farm-raised fish species have a clear need for these nutrients. Farmed fish deposit the LC omega-3s in their flesh and transfer them up ... ...

    Abstract Low-trophic-level fish are a crucial source of long-chain (LC) omega-3 fatty acids for farmed fish and humans. Many farm-raised fish species have a clear need for these nutrients. Farmed fish deposit the LC omega-3s in their flesh and transfer them up the food chain. However, the content of LC omega-3s in farm-raised seafood continues to decline, while the content of shorter-chain plant-sourced omega-3s, and pro-inflammtory omega-6s continue to increase. This reduces its nutritional worth. The value of low-trophic-level fish is often viewed merely as its price at the dock. Some reports and metrics steer public attention towards the mass balance between quantities of low-trophic-level fish and farmed seafood. However, the the nutritional value of seafood is more important than its mere quantities. The role of low-trophic-level fish in human nutrition, health, and wellbeing is a fundamental component of its economic value to society.
    Language English
    Publishing date 2015-04-26
    Publishing country England
    Document type Journal Article
    ZDB-ID 1053078-2
    ISSN 0956-666X
    ISSN 0956-666X
    DOI 10.1002/lite.201500006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Fish and fish oil in health and disease prevention

    Raatz, Susan K / Bibus, Douglas M

    2016  

    Author's details edited by Susan K. Raatz, Douglas M. Bibus
    MeSH term(s) Fish Oils/therapeutic use ; Seafood ; Nutritional Physiological Phenomena
    Language English
    Size xiii, 366 pages :, illustrations ;, 29 cm
    Document type Book
    ISBN 0128028440 ; 9780128028445
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  5. Book: Fish and fish oil in health and disease prevention

    Raatz, Susan K / Bibus, Douglas M

    2016  

    Author's details edited by Susan K. Raatz, Douglas M. Bibus
    Keywords Fish oils in human nutrition. ; Fish oils/Health aspects. ; Seafood/Health aspects. ; fish oils
    Language English
    Size xiii, 366 pages :, illustrations ;, 29 cm
    Document type Book
    ISBN 0128028440 ; 9780128028445
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article: The role of Omega‐3 docosapentaenoic acid in pregnancy and early development

    Li, Juan / Douglas M. Bibus / Huaixia Yin / Oleksandr A. Byelashov

    European journal of lipid science and technology. 2016 Nov., v. 118, no. 11

    2016  

    Abstract: Docosapentaenoic acid (DPA, 22:5n‐3) is normally present in small quantities in marine products. Metabolically, it can directly convert to docosahexaenoic acid (DHA, 22:6n‐3) and retro‐convert into eicosapentaenoic acid (EPA, 20:5n‐3), suggesting ...

    Abstract Docosapentaenoic acid (DPA, 22:5n‐3) is normally present in small quantities in marine products. Metabolically, it can directly convert to docosahexaenoic acid (DHA, 22:6n‐3) and retro‐convert into eicosapentaenoic acid (EPA, 20:5n‐3), suggesting that it may serve as a reservoir for these fatty acids in human body. Among other biological functions, DPA serves a precursor to anti‐inflammatory and pro‐resolving mediators. Further, either consumption of DPA or its blood levels are associated with positive human health outcomes, and in vitro and in vivo models have confirmed and highlighted DPA's biological role in mammals. Because the role of DHA in prenatal and postnatal development is well known, most infant formulas are now supplemented with DHA. Although human breast milk contains significant levels of DHA, importantly, its levels of DPA are comparable. Despite this, the importance of DPA in infant and maternal health is less recognized. Our review highlights that DPA intake (often along with EPA and DHA) by lactating mothers is linked to better neural development and bone health of children. Additionally, blood levels of DPA in mothers are associated with fewer allergic diseases such as asthma, rhinitis, and eczema in children and mothers. The daily dietary intake of DPA in breast‐fed infants in various populations ranges from 5.1 to 44.6 mg/kg body weight, which would translate to 357–3122 mg/d for a 70‐kg adult. The reported health effects of DPA suggest it may be beneficial to increase the intake of DPA during prenatal and early postnatal life stages. Practical applications: This paper reviewed all research articles related with DPA health benefits in human development and summarized the potential function of DPA in human during pregnancy and early development. In vitro and in vivo studies both indicated that DPA has important biological role in mammals. The fact that DPA is high in human breast milk shows the potential biological function of DPA in infant development. The authors recommend infant formula manufacturers to consider adding DPA to infant food and encourage researchers to conduct human clinical studies to further prove the biological function of DPA in human development. LC Omega‐3 fatty acids play a critical role in human nutrition and health. DPA's role as a reservoir for DHA and EPA highlights the importance in human physiology. This study demonstrates the association between blood DPA levels and both infant and maternal health, and suggests the recommendation for DPA consumption during prenatal and early postnatal life stages.
    Keywords adults ; asthma ; blood ; body weight ; breast feeding ; breast milk ; children ; clinical trials ; docosahexaenoic acid ; docosapentaenoic acid ; early development ; eczema ; eicosapentaenoic acid ; food intake ; human health ; human nutrition ; human physiology ; in vivo studies ; infant development ; infant formulas ; infants ; lactating women ; lactation ; models ; mothers ; neurodevelopment ; omega-3 fatty acids ; postnatal development ; pregnancy ; rhinitis
    Language English
    Dates of publication 2016-11
    Size p. 1692-1701.
    Publishing place John Wiley & Sons, Ltd
    Document type Article
    Note JOURNAL ARTICLE
    ZDB-ID 2003265-1
    ISSN 1438-7697
    ISSN 1438-7697
    DOI 10.1002/ejlt.201600076
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  7. Article ; Online: Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?

    Donadio, James V / Bergstralh, Eric J / Bibus, Douglas M / Grande, Joseph P

    Clinical journal of the American Society of Nephrology : CJASN

    2006  Volume 1, Issue 5, Page(s) 933–939

    Abstract: Re-analysis of the North American IgA Nephropathy Study suggested that efficacy of omega-3 polyunsaturated fatty acids (omega-3 PUFA) was dosage-dependent on the basis of body size and plasma omega-3/omega-6 and eicosapentaenoic acid (EPA)/arachidonic ... ...

    Abstract Re-analysis of the North American IgA Nephropathy Study suggested that efficacy of omega-3 polyunsaturated fatty acids (omega-3 PUFA) was dosage-dependent on the basis of body size and plasma omega-3/omega-6 and eicosapentaenoic acid (EPA)/arachidonic acid (AA) ratios. The objective of this study was to confirm these assertions. Data from a previously reported randomized 2-yr clinical trial in which two dosages of an ethyl ester omega-3 PUFA (Omacor) were given to 73 high-risk patients with IgA nephropathy were reviewed. Omacor also was used in the North American IgA Nephropathy Study. Parameters included body weight; body mass index (BMI); plasma phospholipid AA, EPA, and docosahexanoic acid (DHA) levels and serum creatinine and 24-h urine protein (UP) levels during the 2-yr trial; and time to ESRD after 6.4 yr. Plasma phospholipid levels of EPA, DHA, and EPA/AA ratios were significantly inversely correlated with increasing body weight and BMI in the Omacor 4-g dosage group but not in the Omacor 8-g dosage group. Conversely, increasing levels of lipid parameters were observed with increasing dosages of Omacor (EPA+DHA) in grams per kilogram of body weight at 6 wk of treatment. None of the plasma omega-3 PUFA levels, EPA/AA ratios, or Omacor dosage per kilogram was significantly associated with reciprocal serum creatinine or UP slopes during the 2-yr trial or with ESRD. This post hoc analysis of body weight and BMI, plasma omega-3 PUFA status, and renal outcome did not find that treatment efficacy of omega-3 PUFA was dosage dependent on the basis of body size.
    MeSH term(s) Arachidonic Acid/blood ; Body Mass Index ; Body Size ; Body Weight ; Creatinine/blood ; Disease Progression ; Docosahexaenoic Acids/administration & dosage ; Docosahexaenoic Acids/blood ; Dose-Response Relationship, Drug ; Drug Combinations ; Eicosapentaenoic Acid/administration & dosage ; Eicosapentaenoic Acid/blood ; Glomerulonephritis, IGA/blood ; Glomerulonephritis, IGA/complications ; Glomerulonephritis, IGA/drug therapy ; Glomerulonephritis, IGA/physiopathology ; Humans ; Kaplan-Meier Estimate ; Kidney Failure, Chronic/blood ; Kidney Failure, Chronic/etiology ; Kidney Failure, Chronic/physiopathology ; Phospholipids/blood ; Proportional Hazards Models ; Proteinuria/blood ; Proteinuria/drug therapy ; Proteinuria/etiology ; Proteinuria/physiopathology ; Risk Assessment ; Time Factors ; Treatment Outcome
    Chemical Substances Drug Combinations ; Omacor ; Phospholipids ; Docosahexaenoic Acids (25167-62-8) ; Arachidonic Acid (27YG812J1I) ; Eicosapentaenoic Acid (AAN7QOV9EA) ; Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2006-09
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2226665-3
    ISSN 1555-905X ; 1555-9041
    ISSN (online) 1555-905X
    ISSN 1555-9041
    DOI 10.2215/CJN.00260106
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Enhanced absorption of n-3 fatty acids from emulsified compared with encapsulated fish oil.

    Raatz, Susan K / Redmon, J Bruce / Wimmergren, Nyra / Donadio, James V / Bibus, Douglas M

    Journal of the American Dietetic Association

    2009  Volume 109, Issue 6, Page(s) 1076–1081

    Abstract: Health benefits of n-3 fatty acids are well-established. However, consumption of adequate dietary sources of these fatty acids is inadequate. Oral fish oil supplements are an alternative means of consuming adequate long-chain n-3 fatty acids in ... ...

    Abstract Health benefits of n-3 fatty acids are well-established. However, consumption of adequate dietary sources of these fatty acids is inadequate. Oral fish oil supplements are an alternative means of consuming adequate long-chain n-3 fatty acids in individuals who do not consume sufficient dietary sources. However, palatability can present a problem with compliance. Emulsifying fish oil allows for production of a pleasant-tasting supplement and can enhance digestion and absorption of the fatty acids. We investigated the rate and extent of absorption of emulsified fish oil compared with capsular triglyceride fish oil supplements in humans. Participants subjectively rated palatability of these products. A randomized, crossover-designed, open-label trial was performed in which 10 healthy volunteers received emulsified fish oil and capsular triglyceride fish oil orally. Blood samples were collected at 0, 2, 4, 8, 24, and 48 hours to determine the absorption of individual fatty acids into plasma phospholipid fatty acids. At the completion of blood collection, subjects were asked to subjectively rate the tolerance and acceptability of the two supplements. During a 48-hour period, there was enhanced absorption of total n-3 and eicosapentaenoic acid (0.67%+/-0.16%, 0.45%+/-0.06%; P<0.01; 0.34%+/-0.05%, 0.23%+/-0.04%; P=0.05; emulsified fish oil and capsular triglyceride fish oil, respectively) observed for the emulsified fish oil treatment. Our findings indicate that a single dose of emulsified fish oil resulted in enhanced absorption of total n-3 eicosapentaenoic acid and docosahexaenoic acid as evidenced by changes in phospholipid fatty acids composition compared with the capsular triglyceride fish oil during the 48-hour observation period. Both supplements were subjectively rated and found to be well-tolerated by participants.
    MeSH term(s) Absorption ; Adolescent ; Adult ; Capsules ; Chromatography, Gas ; Cross-Over Studies ; Diet, Fat-Restricted ; Dietary Supplements/analysis ; Emulsions ; Fatty Acids, Omega-3/administration & dosage ; Fatty Acids, Omega-3/blood ; Fatty Acids, Omega-3/pharmacokinetics ; Female ; Humans ; Male ; Middle Aged ; Patient Satisfaction ; Phospholipids/blood ; Surveys and Questionnaires ; Young Adult
    Chemical Substances Capsules ; Emulsions ; Fatty Acids, Omega-3 ; Phospholipids
    Language English
    Publishing date 2009-05-26
    Publishing country United States
    Document type Journal Article ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 390806-9
    ISSN 1878-3570 ; 0002-8223
    ISSN (online) 1878-3570
    ISSN 0002-8223
    DOI 10.1016/j.jada.2009.03.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The influence of dietary lipid composition on skeletal muscle mitochondria from mice following 1 month of calorie restriction.

    Chen, Yana / Hagopian, Kevork / McDonald, Roger B / Bibus, Douglas / López-Lluch, Guillermo / Villalba, José M / Navas, Plácido / Ramsey, Jon J

    The journals of gerontology. Series A, Biological sciences and medical sciences

    2012  Volume 67, Issue 11, Page(s) 1121–1131

    Abstract: To investigate the role mitochondrial membrane lipids play in the actions of calorie restriction (CR), C57BL/6 mice were assigned to four groups (control and three 40% CR groups) and fed diets containing soybean oil (also in the control diet), fish oil, ... ...

    Abstract To investigate the role mitochondrial membrane lipids play in the actions of calorie restriction (CR), C57BL/6 mice were assigned to four groups (control and three 40% CR groups) and fed diets containing soybean oil (also in the control diet), fish oil, or lard. The fatty acid composition of the major mitochondrial phospholipid classes, proton leak, and H(2)O(2) production were measured in muscle mitochondria following 1 month of CR. The results indicate that phospholipid fatty acids reflected the polyunsaturated fatty acid profile of the dietary lipid sources. Capacity for Complex I- and III-linked H(2)O(2) production was decreased with CR, although there was no difference between CR groups. The CR lard group had lower proton leak than all other groups. The results indicate that a decreased degree of unsaturation in muscle mitochondrial membranes is not required for reduced H(2)O(2) production with CR. However, dietary lipids do have some influence on proton leak with CR.
    MeSH term(s) Analysis of Variance ; Animals ; Body Weight ; Caloric Restriction ; Dietary Fats/metabolism ; Disease Models, Animal ; Fatty Acids/metabolism ; Lipid Metabolism/physiology ; Male ; Mice ; Mice, Inbred C57BL ; Mitochondria, Muscle/metabolism ; Organ Size ; Oxidative Phosphorylation ; Oxygen Consumption ; Random Allocation ; Reference Values ; Risk Factors ; Statistics, Nonparametric ; Time Factors
    Chemical Substances Dietary Fats ; Fatty Acids
    Language English
    Publishing date 2012-04-13
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1223643-3
    ISSN 1758-535X ; 1079-5006
    ISSN (online) 1758-535X
    ISSN 1079-5006
    DOI 10.1093/gerona/gls113
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Enhanced Absorption of n-3 Fatty Acids from Emulsified Compared with Encapsulated Fish Oil

    Raatz, Susan K / Redmon, J. Bruce / Wimmergren, Nyra / Donadio, James V / Bibus, Douglas M

    Journal of the American Dietetic Association. 2009 June, v. 109, no. 6

    2009  

    Abstract: Health benefits of n-3 fatty acids are well-established. However, consumption of adequate dietary sources of these fatty acids is inadequate. Oral fish oil supplements are an alternative means of consuming adequate long-chain n-3 fatty acids in ... ...

    Abstract Health benefits of n-3 fatty acids are well-established. However, consumption of adequate dietary sources of these fatty acids is inadequate. Oral fish oil supplements are an alternative means of consuming adequate long-chain n-3 fatty acids in individuals who do not consume sufficient dietary sources. However, palatability can present a problem with compliance. Emulsifying fish oil allows for production of a pleasant-tasting supplement and can enhance digestion and absorption of the fatty acids. We investigated the rate and extent of absorption of emulsified fish oil compared with capsular triglyceride fish oil supplements in humans. Participants subjectively rated palatability of these products. A randomized, crossover-designed, open-label trial was performed in which 10 healthy volunteers received emulsified fish oil and capsular triglyceride fish oil orally. Blood samples were collected at 0, 2, 4, 8, 24, and 48 hours to determine the absorption of individual fatty acids into plasma phospholipid fatty acids. At the completion of blood collection, subjects were asked to subjectively rate the tolerance and acceptability of the two supplements. During a 48-hour period, there was enhanced absorption of total n-3 and eicosapentaenoic acid (0.67%±0.16%, 0.45%±0.06%; P<0.01; 0.34%±0.05%, 0.23%±0.04%; P=0.05; emulsified fish oil and capsular triglyceride fish oil, respectively) observed for the emulsified fish oil treatment. Our findings indicate that a single dose of emulsified fish oil resulted in enhanced absorption of total n-3 eicosapentaenoic acid and docosahexaenoic acid as evidenced by changes in phospholipid fatty acids composition compared with the capsular triglyceride fish oil during the 48-hour observation period. Both supplements were subjectively rated and found to be well-tolerated by participants.
    Keywords dietary fat ; omega-3 fatty acids ; fish oils ; dietary nutrient sources ; randomized clinical trials ; emulsions ; fat intake ; lipolysis ; nutrient availability ; intestinal absorption ; microencapsulation ; blood lipids ; fatty acid composition ; triacylglycerols ; oral administration ; dietary supplements ; eicosapentaenoic acid ; docosahexaenoic acid
    Language English
    Dates of publication 2009-06
    Size p. 1076-1081.
    Document type Article
    ZDB-ID 390806-9
    ISSN 1878-3570 ; 0002-8223
    ISSN (online) 1878-3570
    ISSN 0002-8223
    DOI 10.1016/j.jada.2009.03.006
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top